AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16270608
Drug: Inhaled sevoflurane
RxNorm normalized name: sevoflurane Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled sevoflurane with incremental doses of fentanyl
Trial: 2249378
Drug: labetalol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: labetalol (200 to 1600 mg/day)
Trial: 3042356
Drug: atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (50 to 100 mg/day)
Trial: 7317247
Drug: Equipotent doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equipotent doses (UD95) of thiopentone
Trial: 7317247
Drug: Equipotent doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equipotent doses (UD95) of Althesin
Trial: 31202641
Drug: Bempedoic acid
RxNorm normalized name: bempedoic acid
DrugBank: Bempedoic acid (DB11936)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Bempedoic acid 180 mg
Trial: 23981722
Drug: Black seed
RxNorm normalized name: BLACK SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black seed oil (40-80 mg/kg/day)
Trial: 12575606
Drug: Sini Decoction
RxNorm normalized name: Ephedra sinica root
DrugBank: Ephedra sinica root (DB01363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sini Decoction (SND) treatment
Trial: 12575606
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no SND treatment)
Trial: 8201388
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (FAC: fluorouracil, doxorubicin, and cyclophosphamide)
Trial: 8622020
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (FAC)
Trial: 3365530
Drug: Low-dose indomethacin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose indomethacin (50 mg/day) combined with paracetamol (4 g/day)
Trial: 3365530
Drug: High-dose indomethacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose indomethacin (150 mg/day)
Trial: 30932313
Drug: Immediate-release tacrolimus
RxNorm normalized name: tacrolimus Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release tacrolimus (IR-T)
Trial: 24775991
Drug: Intravenous ghrelin
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ghrelin 3 mcg/kg
Trial: 24775991
Drug: Intravenous ghrelin
RxNorm normalized name: Ghrelin
DrugBank: Lenomorelin (DB11895)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ghrelin 1 mcg/kg
Trial: 24775991
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mcg/kg)
Trial: 18284597
Drug: RB006 (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RB006 (0.75 mg kg(‐1) intravenous bolus) followed by RB007 (2:1 to 0.125:1 antidote/drug ratio, 1.5 mg kg(‐1) to 0.094 mg kg(‐1))
Trial: 11837528
Drug: Speech and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speech and language therapy for aphasia following stroke
Trial: 9522243
Drug: Topical isotretinoin
RxNorm normalized name: isotretinoin Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical isotretinoin gel 0.05%
Trial: 9522243
Drug: Topical retinoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical retinoic acid cream 0.05%
Trial: 385402
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of betamethasone dipropionate + betamethasone phosphate (Diprospan)
Trial: 385402
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of methylprednisolone acetate (Depomedrol)
Trial: 19453049
Drug: Sedation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedation with midazolam 0.1 mg/kg, propofol 1 mg/kg, and fentanyl 1 microg/kg intravenously
Trial: 16442399
Drug: 1.8 g
RxNorm normalized name: Calciquid, 1.8 g/5 mL oral syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g of soy stanols
Trial: 14586625
Drug: HBO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBO therapy (Hyperbaric oxygen) added to steroids, plasma expander dextrans, diazepam, pentoxiphylline and salt restriction
Trial: 14586625
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (steroids, plasma expander dextrans, diazepam, pentoxiphylline and salt restriction)
Trial: 3679620
Drug: Dextromethorphan (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (60 mg single dose) - Resilar
Trial: 3679620
Drug: Dextromethorphan (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (60 mg single dose) - Redol comp.
Trial: 3679620
Drug: Dextromethorphan (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan (60 mg single dose) - Extuson
Trial: 29845764
Drug: LE-tablet computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LE-tablet computer use
Trial: 24199672
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioural treatment (ICBT) supported by short face-to-face consultations (MoodGYM)
Trial: 16969350
Drug: Surgery followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery followed by adjuvant chemotherapy (UFT 400 mg day-1 for 1 year) in stage I patients (group B)
Trial: 16969350
Drug: Surgery followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery followed by chemotherapy (cisplatin and vindesine followed by UFT) in stage II or IIIA patients (group D)
Trial: 2897912
Drug: Succinylcholine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine (1 mg kg‐1)
Trial: 18405411
Drug: Rocuronium (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.6 mg kg‐1)
Trial: 9649995
Drug: Rocuronium (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.9 mg kg‐1)
Trial: 8804380
Drug: Hepatitis C
RxNorm normalized name: hepatitis C virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis C vaccine
Trial: 3484960
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate with leucovorin calcium rescue (23 patients)
Trial: 3484960
Drug: No chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No chemotherapy (19 patients)
Trial: 22796761
Drug: Single subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single subcutaneous injection of CMAB001 at doses of 0.5, 1.0, or 2.0 mg/kg
Trial: 22796761
Drug: Weekly subcutaneous
RxNorm normalized name: Weekly Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly subcutaneous injections of CMAB001 at a dose of 1.0 mg/kg for 7 weeks
Trial: 20163324
Drug: Albuterol/ipratropium bromide
RxNorm normalized name: albuterol/ipratropium bromide 20/100 MCG/INHAL Metered Dose Inhalation Spray, 120 Actuations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol/ipratropium bromide combination therapy
Trial: 19115911
Drug: SHAM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHAM treatment for 6 to 7 consecutive days
Trial: 18396244
Drug: Antidepressant users
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant users (36.2% of participants, n = 50)
Trial: 18396244
Drug: Other prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other prescription medications
Trial: 11725980
Drug: Multipurpose solution
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multipurpose solution with HPMC
Trial: 8384232
Drug: 0.1% RA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% RA cream
Trial: 8384232
Drug: 0.001% RA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.001% RA cream
Trial: 3609120
Drug: Omeprazole 60
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 60 mg daily for 1 week
Trial: 23932463
Drug: Fimasartan 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fimasartan 60 mg/d
Trial: 23932463
Drug: Fimasartan 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fimasartan 120 mg/d
Trial: 14504090
Drug: Itraconazole (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (intravenous 200 mg daily, or oral solution 2.5 mg/kg 3 times daily)
Trial: 14504090
Drug: Fluconazole (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (intravenous or oral, 400 mg daily)
Trial: 11342474
Drug: IL-6 genotype
RxNorm normalized name: IL-6
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-6 genotype (‐174 G‐‐>C polymorphism)
Trial: 9412794
Drug: Flutamide 250
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 250 mg tid
Trial: 30203762
Drug: Ibandronate needle
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate needle therapy
Trial: 30203762
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid needle therapy
Trial: 27344665
Drug: Piribedil (150–300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piribedil (150–300 mg/day, three times daily)
Trial: 18397687
Drug: Serlift (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serlift (50 mg)
Trial: 18397687
Drug: Zoloft (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zoloft (50 mg)
Trial: 12371727
Drug: Ultrafiltration at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrafiltration at 20 ml/h-1/kg-1 (group 1, n = 146)
Trial: 12371727
Drug: Ultrafiltration at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrafiltration at 35 ml/h-1/kg-1 (group 2, n = 139)
Trial: 12371727
Drug: Ultrafiltration at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrafiltration at 45 ml/h-1/kg-1 (group 3, n = 140)
Trial: 9666415
Drug: Leflunomide 25
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leflunomide 25 mg once daily
Trial: 9666415
Drug: Leflunomide 10
RxNorm normalized name: leflunomide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide 10 mg daily
Trial: 9666415
Drug: Leflunomide 10
RxNorm normalized name: leflunomide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide 10 mg and 25 mg
Trial: 2688186
Drug: HR capsules
RxNorm normalized name: Synovex H
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HR capsules (1,200 mg/day)
Trial: 12457672
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and retrobulbar anesthesia
Trial: 3901934
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration therapy (high sodium isotonic fluid at 40 ml/kg per hour during rehydration phase, low sodium isotonic fluid during maintenance phase)
Trial: 31699150
Drug: Apatinib (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib (500 mg, p.o. q.d.) plus gefitinib (250 mg, p.o. q.d.)
Trial: 17671066
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray (5 mg)
Trial: 15616064
Drug: Adenosine triphosphate
RxNorm normalized name: Adenosine triphosphate
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine triphosphate 0.1 mg.kg(‐1).min(‐1)
Trial: 1080266
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg methylergonovine maleate (Methergine) intramuscularly
Trial: 31068125
Drug: Message 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Message 2 (depression needs treatment)
Trial: 31068125
Drug: Message 3
RxNorm normalized name: histamine
DrugBank: Histamine (DB05381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Message 3 (depression improves with treatment)
Trial: 19381735
Drug: Probiotics (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (2.4 billion colonies of Lactobacillus administered daily postoperatively)
Trial: 14679122
Drug: Irinotecan (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan (180 mg/m²) with 5‐fluorouracil (400 mg/m² bolus) and leucovorin (125 mg/m²) followed by 5‐FU (1200 mg/m² infusion over 48 h) every 2 weeks
Trial: 14679122
Drug: Irinotecan and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan and 5‐fluorouracil treatment
Trial: 7699621
Drug: Azathioprine (AZA)
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine (AZA) treatment
Trial: 7950184
Drug: Kuiyangqing Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kuiyangqing Pill (KYQP) for EHS group
Trial: 7950184
Drug: Bismuth aluminate
RxNorm normalized name: BISMUTH ALUMINATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth aluminate tablets (control) for EHS group
Trial: 7950184
Drug: Kuiyangqing Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kuiyangqing Pill (KYQP) for DCS group
Trial: 7950184
Drug: Bismuth aluminate
RxNorm normalized name: BISMUTH ALUMINATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth aluminate tablets (control) for DCS group
Trial: 3109990
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of rioprostil
Trial: 24972907
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment programme (STP)
Trial: 23296827
Drug: Tannin diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tannin diet (20 g DM of alfalfa hay/kg BW supplemented with 50 g of quebracho/kg DM)
Trial: 23296827
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (20 g DM of alfalfa hay/kg BW)
Trial: 21723792
Drug: Paclitaxel, Bevacizumab,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel, Bevacizumab, and Gemcitabine (PB+G)
Trial: 17111014
Drug: Caffeine (CAFF;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (CAFF; 5 mg/kg body mass)
Trial: 15679253
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and its derivatives with radiation therapy
Trial: 9485982
Drug: Tramadol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1 mg.kg‐1)
Trial: 9485982
Drug: Morphine (0.09
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.09 mg.kg‐1)
Trial: 3540140
Drug: Aminoglycoside therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminoglycoside therapy (gentamicin, tobramycin, amikacin)
Trial: 29030199
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg iodine orally once a day until delivery
Trial: 26319820
Drug: Low-fat, phytosterol-supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat, phytosterol-supplemented milk (2.24 gr of plant sterols daily)
Trial: 23810643
Drug: 400 mL
RxNorm normalized name: Lantidra 400 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mL of beer
Trial: 23810643
Drug: 800 mL
RxNorm normalized name: ALCOHOL 2660 mL in 3800 mL TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mL of dealcoholized beer
Trial: 23810643
Drug: 67 mL
RxNorm normalized name: ethanol 0.67 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 67 mL of vodka and 733 mL water
Trial: 18826157
Drug: Shen Shuai
RxNorm normalized name: Ren shen
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shen Shuai Fang + western medicine
Trial: 10868311
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) interferon alfa‐n3 (10 million units)
Trial: 10868311
Drug: Intramuscular (i.m.)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (i.m.) interferon alfa‐n3 (10 million units)
Trial: 10868311
Drug: Subcutaneous (SQ)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SQ) interferon alfa‐n3 (10 million units)
Trial: 1417314
Drug: Endolymphatic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endolymphatic administration of kanamycin
Trial: 1417314
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of kanamycin
Trial: 1417314
Drug: Lymphotropic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lymphotropic administration of kanamycin
Trial: 1417314
Drug: Endolymphatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endolymphatic therapy during postoperative period
Trial: 6519841
Drug: Nicardipine 20
RxNorm normalized name: nicardipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 20 mg, four times a day for 3 weeks
Trial: 6519841
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg, four times a day for 3 weeks
Trial: 30383495
Drug: IDegLira (insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDegLira (insulin degludec/liraglutide)
Trial: 26093599
Drug: Dehydroepiandrosterone (DHEA)
RxNorm normalized name: DEHYDROEPIANDROSTERONE (DHEA) CAP/TAB
DrugBank: Prasterone sulfate (DB05804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dehydroepiandrosterone (DHEA) 100 mg
Trial: 15054445
Drug: Haematopoietic growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haematopoietic growth factors (HGF) plus chemotherapy
Trial: 9626025
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 micrograms once daily
Trial: 9626025
Drug: Formoterol 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 6 micrograms twice daily
Trial: 9626025
Drug: Terbutaline 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 500 micrograms four times daily
Trial: 26718065
Drug: Peripheral intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral intravenous cannulae (PIVC) inserted
Trial: 23941313
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment for depression
Trial: 21075578
Drug: Morphine and
RxNorm normalized name: morphine and antispasmodics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine and ultra-low-dose naltrexone
Trial: 21075578
Drug: Morphine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine alone (with placebo)
Trial: 20207004
Drug: Parenting skills
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenting skills training (2-hour weekly sessions for 2 weeks)
Trial: 15816462
Drug: Methylprednisolone (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (500 mg/body) in saline 2 hours before surgery
Trial: 12166555
Drug: Montelukast (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (5 mg) and Loratadine (10 mg)
Trial: 8092839
Drug: Lomefloxacin 400
RxNorm normalized name: lomefloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomefloxacin 400 mg once daily for 14 days
Trial: 8092839
Drug: Trimethoprim-sulfamethoxazole 160/800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days
Trial: 3041830
Drug: Intramuscular cefamandole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular cefamandole
Trial: 27999758
Drug: GPC3 peptide
RxNorm normalized name: Peptide T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GPC3 peptide vaccine
Trial: 1442957
Drug: RU 486
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 486 (1 mg/day orally)
Trial: 22570949
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg every 12 hours for 3 months)
Trial: 19952722
Drug: Supplemental protective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental protective drug (thiopental or etomidate), n = 178
Trial: 17609936
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory drug (diclofenac 50 mg)
Trial: 16197471
Drug: Oral suplatast
RxNorm normalized name: Suplatast
DrugBank: Suplatast (DB19138)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral suplatast 300 mg daily for 3 months